FAQ: Where US Pharma Reshoring Stands in 2026

Why It Matters

For operators, pharma reshoring matters because it can change domestic production capacity, supplier qualification needs, and sourcing risk. For investors and supply chain leaders, the key implications are capex requirements, labor availability, margin pressure, and how much production can realistically shift closer to U.S. demand.